Zynerba Pharmaceuticals Inc

Zynerba Pharmaceuticals Inc is a clinical-stage pharmaceutical company dedicated to developing innovative cannabinoid therapeutics. The company is based in the US and delivers innovative drugs for rare and complex neurological and psychiatric disorders. Operating within the biotechnology sector, Zynerba Pharmaceuticals Inc specialises in synthetic cannabinoid treatments delivered via transdermal . Its proprietary transdermal cannabinoid product, Zygel offers a new, non-oral treatment for central nervous system disorders. Add this stock to your eToro watchlist to receive news and updates on the ZYNE share price. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.